Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Paroxetine Dosing in Renal Impairment

Rationale for No Dose Adjustment

  • Paroxetine, like other SSRIs, is primarily metabolized by the liver rather than cleared by the kidneys, making it safe to use at standard doses in patients with impaired renal function 1
  • Similar to other psychotropic medications that undergo hepatic metabolism, paroxetine's pharmacokinetics are not significantly altered in renal failure 1

Clinical Considerations

Dosing Recommendations

  • Standard adult dosing of paroxetine can be maintained in all stages of renal impairment, including mild to moderate renal impairment, severe renal impairment, and end-stage renal disease requiring hemodialysis 1

Comparison with Other Medications

  • Similar to paroxetine, other medications that do not require renal dose adjustment include NNRTIs and protease inhibitors used in HIV treatment, and most antidepressants that undergo hepatic metabolism 1
  • Certain antibiotics, such as aminoglycosides and fluoroquinolones, require dose adjustment in renal impairment 2
  • Antituberculosis drugs like pyrazinamide and ethambutol also require dose adjustment in renal impairment 3, 4

Special Populations

  • Elderly patients with decreased renal function may be more sensitive to side effects even with normal dosing 5